Calcium and Vitamin D Supplements Show Little to No Benefit for Fracture and Fall Prevention, Major BMJ Review Finds

A sweeping systematic review and meta-analysis published in The BMJ has concluded that calcium查看药品详情, vitamin D查看药品详情, and combined supplementation provide little to no clinically meaningful benefit for preventing fractures and falls in the general adult population. The findings challenge decades of routine clinical recommendations and raise questions about billions of dollars in annual consumer spending on these supplements.

The analysis, conducted by researchers in Canada, examined 69 randomized controlled trials encompassing 153,902 adults. Studies compared calcium查看药品详情 supplements, vitamin D查看药品详情 supplements, or a combination of both against placebo or no treatment. The evidence was rated as moderate to high certainty across the key findings.

"Based on absolute risk reductions and thresholds considered clinically meaningful, this review found little to no benefits from use of calcium查看药品详情, vitamin D查看药品详情, or combined supplementation on the prevention of fractures and falls," the authors concluded.

No Meaningful Reduction Across Supplement Types

The review found that calcium查看药品详情 monotherapy showed no impact on fractures, with confidence intervals for absolute risk differences too wide to reliably demonstrate a true benefit. Vitamin D查看药品详情 monotherapy similarly demonstrated no benefit — a finding the researchers emphasized as particularly notable, since "it can't hurt" does not apply to vitamin D alone given the clear absence of effect.

Combination therapy with calcium查看药品详情 and vitamin D查看药品详情 also failed to produce clinically meaningful results. While three studies showed an improvement of less than 1%, this was deemed below the acceptable clinical minimum.

The findings extended to specific fracture types, including hip fractures, and to fall prevention. These results were supported largely by moderate to high certainty evidence.

Consistency Across Subgroups

Additional analyses produced similar results even after accounting for factors such as age, sex, previous fractures, previous falls, and average calcium查看药品详情 intake from food. According to the researchers, this consistency strengthens confidence in the overall conclusions.

The authors did caution that the findings may not apply to people with certain bone disorders or to those receiving medication for osteoporosis (搜索)搜索该疾病. They also noted that some parts of the analysis included relatively few studies and participants, warranting careful interpretation.

The Gap Between Evidence and Guidelines

The disconnect between evidence and practice is striking. A systematic review of multiple medical guidelines found that 70% recommended vitamin D查看药品详情 supplements to prevent fractures or for general health. Prescriptions for these supplements have also risen considerably in recent years.

How did so many guidelines get it wrong? The review suggests an answer rooted in how clinical research is conducted. Early trials of vitamin D查看药品详情 and calcium查看药品详情 supplementation reported significant reductions in fractures — an absolute reduction of 2.5% for hip fractures and a relative reduction of 23%. However, those study populations were enriched with older women (mean age 84) with low dietary intakes of calcium and vitamin D, all requiring residential care.

These findings, the researchers argue, were never generalizable to community-dwelling adults without documented deficiencies — precisely the broader population that became the target market for supplementation.

"To identify small but pertinent effects, researchers often choose populations with a higher incidence of a condition to generate a strong statistical association," the analysis explains. "The only way to demonstrate a small effect is either with a very large population, which can be costly and time-consuming, or by enriching the population with more at-risk individuals."

Clinical Significance and NNT Context

To contextualize the findings, the number needed to treat (NNT) provides a useful comparison. For bisphosphonates (搜索)搜索该药品 used to treat bone loss when medically indicated, the NNT to prevent a fracture is roughly 10. For statins to reduce myocardial infarctions, the NNT is 77. The NNTs for calcium查看药品详情 and vitamin D查看药品详情 supplementation fall far outside any clinically meaningful range for the general population.

The researchers also noted that calcium查看药品详情 supplementation can cause mild but bothersome gastrointestinal effects, including constipation, bloating, and abdominal pain.

Shifting Toward Proven Strategies

In a linked editorial, researchers argue that resources and funding may be better directed toward strategies that have already demonstrated meaningful benefits for fall and fracture prevention. These include balance training, resistance exercise, and personalized fall prevention programs that combine approaches such as exercise, hazard assessment, and education based on an individual's specific risk factors.

The authors of the review recommend that clinicians, guideline panels, and regulatory agencies "should re-evaluate their general recommendations for calcium查看药品详情 and vitamin D查看药品详情 supplementation in light of current evidence."

For individuals with documented deficiencies, poor dietary intake, osteoporosis (搜索)搜索该疾病, malabsorption, or other clear medical indications, supplementation retains its role. But for the broad population of adults living at home who take these supplements as insurance against fractures, the evidence increasingly shows the policy pays little.

An estimated $1–3 billion is spent annually by Americans without a clear medical indication on calcium查看药品详情 and vitamin D查看药品详情 supplements taken to promote bone health. As the review makes clear, "it can't hurt" is not the same as "it helps."